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Abstract. Agrin is thought o be the nerve-derived fac- 
tor that initiates acetylcholine r ceptor (AChR) clus- 
tering at the developing neuromuscular junction. We 
have investigated the signaling pathway in mouse C2 
myotubes and report hat agrin induces a rapid but 
transient tyrosine phosphorylation f the AChR 13 sub- 
unit. As the 13-subunit tyrosine phosphorylation ccurs 
before the formation of AChR clusters, it may serve as 
a precursor step in the clustering mechanism. Consis- 
tent with this, we observed that tyrosine phosphoryla- 
tion of the [3 subunit correlated precisely with the 
presence or absence of clustering under several experi- 
mental conditions. Moreover, two tyrosine kinase in- 
hibitors, herbimycin and staurosporine, that blocked 
B-subunit phosphorylation also blocked agrin-induced 
clustering. Surprisingly, the inhibitors also dispersed 
preformed AChR clusters, suggesting that the tyrosine 
phosphorylation f other proteins may be required for 
the maintenance of receptor clusters. These findings in- 
dicate that in mammalian muscle, agrin-induced AChR 
clustering occurs through a mechanism that requires ty- 
rosine phosphorylation a d may involve tyrosine phos- 
phorylation of the AChR itself. 
T 
HE accumulation of acetylcholine receptors 
(AChR) 1 beneath the nerve terminal is one of the 
first discernible steps in synapse formation at the 
neuromuscular junction (Hall and Sanes, 1993). The con- 
centration of AChRs in the postsynaptic muscle membrane 
is induced by the nerve and is due both to clustering of the 
preexisting receptor and to local insertion of the newly 
synthesized receptor. Agrin is thought o be the nerve- 
derived factor that induces the initial redistribution of the 
AChR (McMahan, 1990; Ferns and Hall, 1992), as well as 
the accumulation of several other synaptic components 
(Wallace, 1989). Although agrin is expressed inembryonic 
muscle and in other nonneural tissues, neurons ynthesize 
a specific isoform of agrin, generated by alternative RNA 
splicing, that is significantly more biologically active than 
the forms found in muscle (Ruegg et al., 1992; Tsim et al., 
1992; Ferns et al., 1993; Hoch et al., 1993). Neurally de- 
rived agrin is believed to cluster AChRs by acting on a 
specific receptor in the myotube membrane. Several 
groups have recently shown that the predominant agrin- 
binding protein in muscle is et-dystroglycan (Bowe et al., 
1994; Campanelli et al., 1994; Gee et al., 1994; Sugiyama et 
Address all correspondence to Z.W. Hall, Office of the Director, Bldg. 31, 
Room 8A52, National Institute of Neurological Disorders and Stroke, Na- 
tional Institutes of Health, Bethesda, MD 20892. Tel.: (301) 496-9746. Fax: 
(301) 496-0296. 
i. Abbreviation used in this paper. AChR, acetylcholine r ceptor. 
al., 1994), a cell surface protein that is part of a transmem- 
brane complex of proteins associated with dystrophin. 
There is conflicting data, however, as to whether ot-dystro- 
glycan is the signaling receptor esponsible for the initia- 
tion of AChR clusters, and other oles for the protein have 
been suggested (Sealock and Froehner, 1994; Sugiyama et 
al., 1994; Fallon and Hall, 1994). 
Although the receptor for agrin and its mode of signal- 
ing are not yet established, recent evidence suggests that 
tyrosine phosphorylation may be part of the signaling 
pathway, at least in chick muscle (Wallace et al., 1991; Qu 
and Huganir, 1994). Many growth and differentiation fac- 
tors activate receptor or cytoplasmic tyrosine kinases 
(Schlessinger and Ullrich, 1992; Kishimoto et al., 1994) 
whose phosphorylation of specific target proteins then 
regulates protein-protein teractions that form the sig- 
naling cascade (Weiss and Littman, 1994). For example, 
tyrosine phosphorylation can result in the binding of other 
proteins via their SH2 domains, leading to the formation 
of signaling complexes, or to the reorganization of cyto- 
skeletal elements. Such a mechanism ay be involved in 
the agrin-induced immobilization and clustering of the 
AChR. 
We have examined whether agrin-induced AChR clus- 
tering in mammalian muscle involves tyrosine phosphory- 
lation. We find that agrin induces a transient yrosine 
phosphorylation f the AChR [3 subunit in mouse C2 myo- 
tube cultures. Moreover, tyrosine kinase inhibitors that 
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block this agrin-induced phosphorylation also block clus- 
tering. Our results indicate that in mammalian muscle, 
agrin-induced AChR clustering occurs through a mecha- 
nism that requires tyrosine phosphorylation a d may in- 
volve tyrosine phosphorylation f the AChR itself. 
Materials and Methods 
Production of Recombinant Agrin 
To produce recombinant agrin in soluble form, we expressed the COOH- 
terminal half of agrin isoforms by transfection i COS cells. We used both 
the most active, neural-specific isoform (C-Ag12,4,8), and the predominant 
muscle isoform (C-Ag12.0.0) (Ferns et al., 1993). COS cells were transiently 
transfected by the DEAE-dextran method, as described previously (Ferns 
et al., 1993), and the media containing the secreted agrin was collected. 
The concentration of agrin was determined using agrin immunoblots, by 
comparing samples of media to a known standard of purified agrin (Ferns 
et al., 1993). 
Assay of Agrin-induced A ChR Clustering 
C2C12 mouse muscle cells, and the variant $26 and $27 lines, were cul- 
tured as previously described (Gordon and Hall, 1989). All experiments 
were performed on 2-3-d-old myotubes grown on 8-well chamber slides 
(Lab-Tek; Miles Laboratories, Inc., NaperviUe, IL). Myotubes were incu- 
bated with neural agrin and stained for the AChR by incubating the live 
cells with rhodamine-conjugated ct-bungarotoxin for 1 h. The cells were 
then rinsed and fixed with 2% paraformaldehyde for 20 min. The levels of 
AChR clustering were compared by determining the average AChR clus- 
ter number in random fields, at a magnification of 400 with a fluorescent 
microscope (E. Leitz, Inc., Rockleigh, N J). 
Tyrosine Kinase Inhibitor Experiments 
We tested the ability of the following tyrosine kinase inhibitors to block 
agrin-induced AChR clustering: methyl 2,5-dihydroxycinnamate, laven- 
dustin A, 2-hydroxy-5-(2,5-dihydroxybenzyl) aminobenzoic acid, genistein, 
reduced carboxamidomethylated an maleylated lysozyme, tyrphostin, 
herbimycin A (Gibco-BRL, Gaithersburg, MD), and staurosporine 
(Sigma Chemical Co., St. Louis, MO). Myotubes were preincubated with 
the inhibitors or a carrier control (DMSO) for 0.5-2 h, and then neural 
agrin was added at ~500 pM for a further 6-8 h. In separate xperiments 
to examine whether the inhibitors dispersed preformed receptor dusters, 
myotubes were treated with neural agrin for 24 h, and then treated with the 
inhibitors for 6--8 h. After these agrin/inhibitor t eatments, the myotubes 
were stained for the AChR, and the levels of AChR clustering were com- 
pared, as described above. All cultures were coded and counted blind. 
To costain for rapsyn (43-kD protein), after fixation the cells were per- 
meabilized in 1% Triton X-100 for 10 min, blocked with 10% horse se- 
rum/PBS, and incubated with the anti-rapsyn antibodies (rnAb 1234A and 
mAb 1579A, provided by S. Froehner) and then an FITC-labeled sheep 
anti-mouse second antibody. 
To confirm that the tyrosine kinase inhibitors were not having nonspe- 
cific effects, we assayed the level of surface AChR. Control and inhibitor- 
treated cultures were incubated with 10 nM 1125 ct-bungarotoxin in fusion 
medium for 2 h to specifically label the surface AChR. The cultures were 
then rinsed and extracted with 0.1 N NaOH, and the level of bound toxin 
was determined with a gamma counter. 
Extraction and Isolation of the A ChR 
To assay AChR subunit yrosine phosphorylation, myotube cultures were 
treated with agrin/inhibitors, rinsed, scraped off in PBS Ca/Mg-free con- 
taining 1 mM sodium orthovanadate, and pelleted. The ceils were then ex- 
tracted in the following buffer containing 1% Triton X-100 (25 mM Tris, 
25 mM glycine, 150 mM NaC1, 5 mM EDTA, 5 mM EGTA, 50 mM NaF, 1 
mM sodium orthovanadate, and the protease inhibitors, PMSF, benzami- 
dine, N-ethylmaleimide, and Na2S406). Insoluble material, such as nuclei 
and extracellular matrix, was removed by centrifugation at 18,000 g for 4 
min. The solubilized AChR was isolated by incubating the extracts with 
a-bungarotoxin conjugated to agarose beads. The proteins isolated on the 
beads were eluted in SDS loading buffer, separated by electrophoresis on
10% polyacrylamide g ls, and transferred to nitrocellulose membranes. 
The proteins were probed with a monoclonal ntiphosphotyrosine a ti- 
body (mAb 4G10), followed by an HRP-conjugated sheep anti-mouse 
second antibody, and then visualized using the enhanced chemilumines- 
cence method (ECL; Amersham Corp., Arlington Heights, IL). To re- 
probe the blots, they were first stripped of antibodies by washing with a 
low pH buffer (200 mM glycine, 0.1% Tween 20, at pH 2.5 for 20 min). 
They were then reprobed for the AChR subunits, both to identify the 
phosphotyrosine immunoreactive bands and to confirm that equal 
amounts of AChR were present in all samples. The ct subunit was identi- 
fied using mAb 210, the 13 subunit using mAb 124, and the 5 subunit using 
mAb 88b (all gifts of J. Lindstrom, University of Pennsylvania, Philadel- 
phia, PA). The level of 13-subunit phosphotyrosine immunoreactivity on
blots was quantified with a scanning spectrophotometer (Du-SB; Beck- 
man Instruments, Inc., Fullerton, CA). 
Results 
Agrin Induces aTransient Tyrosine Phosphorylation f 
the AChR fl Subunit 
The mechanism by which agrin induces AChR clustering 
in mammalian muscle is unclear (Qu et al., 1990). We have 
examined the possibility that aggregation is regulated by 
agrin-induced tyrosine phosphorylation f the AChR it- 
self. To address this question, we have taken advantage of
a simplified system using C2 mouse myotubes and recom- 
binant isoforms of agrin. The myotubes were treated with 
a neural-specific isoform of agrin (C-Ag12.g,s; Ferns et al., 
1993), cell extracts were prepared, and the AChR was par- 
tially purified using et-bungarotoxin conjugated to agarose 
beads. The isolates were separated by PAGE and immu- 
noblotted with an antiphosphotyrosine antibody (4G10). 
Phosphotyrosine-immunoreactive bands were identified 
on the basis of size and by reprobing with AChR subunit- 
specific antibodies. 
We find that agrin treatment induces a rapid but tran- 
sient tyrosine phosphorylation f the 13 subunit (Fig. 1). In 
untreated myotube cultures, there was a low, or often un- 
detectable, level of [3-subunit yrosine phosphorylation. 
After treatment with neural agrin (100 pM), however, 
there was a dramatic increase of phosphorylation that was 
evident by 15 min, peaked between.1 and 3 h, and then de- 
clined. By 8 h, the level of tyrosine phosphorylation was at 
36% of peak level, and by 24 h the level approached, but 
was still slightly above (7%) that seen in the control cul- 
tures (0.5 %). In addition, the time course of tyrosine phos- 
phorylation isconsiderably offset from that of AChR clus- 
tering (Fig. 1 B). Receptor clusters only begin to form 
after 2-4 h of agrin treatment and peak in number at 6--8 h. 
Cluster number then declines lightly, although this ap- 
pears to be due to the coalescence ofsmall clusters. Agrin- 
induced 13-subunit phosphorylation therefore begins at 
least 2 h before the first detectable stages of AChR clus- 
tering. Similarly, the peak of phosphorylation ccurs be- 
fore discernible receptor dusters form, and well before the 
peak of cluster number at 6-8 h (Fig. 1 B). Phosphoryla- 
tion of the 1~ subunit hus may be an early, precursor step 
in the signaling pathway that leads to clustering. 
We did not detect agrin-induced tyrosine phosphoryla- 
tion of the other AChR subunits or of coimmunoprecipi- 
tating proteins. Agrin-induced tyrosine phosphorylation f 
the 5 subunit has been seen in chick, and is reported to be 
sensitive to degradation during boiling in SDS loading buffer 
(Qu and Huganir, 1994). Even using unboiled samples, 
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Figure 1. (A) Agrin induces a transient tyrosine phosphorylation f the AChR 13 subunit. AChR from C2 cultures treated with neural 
agrin (100 pM) over a range of times was isolated on ~t-bungarotoxin beads and immunoblotted with an antiphosphotyrosine a tibody. 
Agrin induces a transient increase in tyrosine phosphorylation f a 49-kD band. Reblotting with the anti-13-subunit antibody (mAb 124) 
confirmed that the phosphotyrosine immunoreactive band corresponds to the t3 subunit, and that equal amounts of the AChR are 
present in each lane. (B) Time course of agrin-induced 13-subunit phosphorylation a d AChR clustering. The level of phosphotyrosine 
immunoreactivity forthe 13 subunit was quantified over an agrin time course and is shown averaged from four experiments. Agrin in- 
duces a pronounced and rapid increase in tyrosine phosphorylation, which peaks at 1-2 h. The increase is transient, however, and has 
decreased to36% of peak at 8 h, and 7% by 24 h. This contrasts with the time course of AChR clustering, where clusters first form at 
2-4 h and peak in number at 6--8 h. 
however, we found no evidence for phosphotyrosine bands 
matching those of the mouse ~ subunit, which we identi- 
fied by immunoblotting with a subunit-specific mAb (88b). 
Tyrosine Phosphorylation of the [3 Subunit Correlates 
with A ChR Clustering 
To determine how closely 13-subunit phosphorylation cor- 
relates with receptor clustering, we examined the extent of 
phosphorylation asa function of agrin concentration. Sets 
of myotube cultures were treated with concentrations of 
neural agrin ranging from 1 pM to 333 pM, and assayed ei- 
ther for 13-subunit phosphorylation r for receptor cluster- 
ing. An agrin-induced increase in the level of 13-subunit 
phosphorylation was first observed at 1-3 pM, and in- 
creased with agrin concentration up to 333 pM, at which 
point it appeared to plateau (Fig. 2). As previously ob- 
served, increased AChR clustering was first observed with 
1-10 pM agrin and continued to increase until a level of 
1 nM. The concentration range over which agrin induces 
AChR phosphorylation thus closely matches that over 
which it induces AChR clusters. 
Similarly, we examined the action of the predominant mus- 
cle isoform of agrin (C-Ag12,0,0) on clustering and 13-subunit 
phosphorylation. Muscle agrin only differs from neural 
agrin in that it lacks two splicing inserts of four and eight 
amino acids, but it has been found to be >10,000-fold less 
active in AChR clustering (Ferns et al., 1993). Muscle 
agrin also fails to block neural agrin-induced clustering 
(Bowen, D.C., J. Sugiyama, M. Ferns, and Z.W. Hall, manu- 
script submitted for publication). Consistent with these ob- 
servations, we find that muscle agrin did not induce 13-sub- 
unit phosphorylation, even at concentrations up to 10 nM 
(Fig. 3 A), and also failed to induce receptor clustering. 
This finding thus further suggests that the signaling recep- 
tor is highly specific for the neural agrin isoform. 
Finally, we examined agrin signaling in two genetic vari- 
ants of C2 cells that are defective in their ability to cluster 
AChRs (Gordon and Hall, 1989; Gordon et al., 1993). The 
$26 and $27 variants have distinct defects in their pro- 
teoglycans, but both show significantly reduced AChR 
clustering when treated with agrin (Ferns et al., 1993). In 
both $26 and $27 myotubes, we found that neural agrin, 
even at a concentration of 100 nM, failed to induce AChR 
13-subunit phosphorylation as well as AChR clustering 
(Fig. 3 B). Moreover, no basal evel of 13-subunit phosphor- 
ylation was detectable in control $26 and $27 cultures, as is 
sometimes seen in C2 myotubes. Thus, under a variety of 
experimental conditions, agrin-induced receptor clustering 
parallels 13-subunit phosphorylation. 
Tyrosine Kinase Inhibitors Block fl-subunit 
Phosphorylation a d A ChR Clustering 
To examine whether 13-subunit yrosine phosphorylation 
plays a critical role in the agrin signaling pathway, we 
tested whether tyrosine kinase inhibitors could block 
phosphorylation and receptor clustering. As previously 
Ferns et al. Agrin-induced AChR Clustering 939 
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Figure 2. 13-subunit tyrosine phosphorylation correlates with agrin concentration. (A) Phosphotyrosine immunobl t of AChR from myo- 
tubes cultures treated with neural agrin at concentrations ranging from i pM to 333 pM. (B) The level of phosphotyrosine immunoreac- 
tivity for the 13 subunit (E]), and the number of AChR clusters (O), were quantified over the agrin concentration range. Agrin first in- 
creases 13-subunit phosphorylation at a concentration f 1-3 pM and approaches maximal phosphorylation from 33 to 100 pM. The level 
of phosphorylation correlates closely with the relative level of AChR clustering induced by agrin at those concentrations. (The receptor 
clustering data is taken from Bowen, D.C., J. Sugiyama, M. Ferns, and Z.W. Hall, manuscript submitted for publication, and was ob- 
tained using the same batch of recombinant agrin). 
described, treatment of myotubes with a soluble form of 
recombinant neural agrin induces a dramatic increase in 
the number of AChR clusters over a 6-8-h period (Fig. 4, 
A and B) (Fems et al., 1993). Two tyrosine kinase inhibi- 
tors, herbimycin A and staurosporine, fficiently blocked 
agrin-induced clustering of receptor (Fig. 4, C and D). Sev- 
eral other tyrosine kinase inhibitors that were tested (see 
Materials and Methods) had no effect. Herbimycin and 
staurosporine blocked agrin-induced clustering in a dose- 
dependent manner (Fig. 5). The 9-11-fold increase in the 
number of AChR clusters induced by agrin was com- 
pletely inhibited by herbimycin and staurosporine, atcon- 
centrations of 0.5 ~M and 5 nM, respectively. These re- 
sults suggest hat the agrin signaling pathway in mouse 
muscle requires tyrosine phosphorylation. 
Moreover, we found that treatment of myotubes with 
herbimycin and staurosporine completely blocked agrin- 
induced tyrosine phosphorylation f the 13 subunit. After a 
6-h preincubation, both inhibitors blocked the initial peak 
of 13-subunit yrosine phosphorylation seen after 1 h of 
agrin treatment (Fig. 6). Similarly, the phosphorylation re- 
maining after 6 h of agrin treatment, when receptor clus- 
ters have formed, was absent in the presence of the inhibi- 
tors (Fig. 6). As 13-subunit phosphorylation is blocked by 
the inhibitors that block AChR clustering, AChR phos- 
phorylation could be a necessary step in the clustering 
mechanism. 
Several ines of evidence indicate that the inhibition is 
not due to a nonspecific, toxic effect on the cells. To ob- 
serve the effect on AChR clustering, myotubes were treated 
with the inhibitors and agrin for the shortest time possible 
(6-8 h) to avoid toxicity due to long-term exposure. After 
both herbimycin and staurosporine treatment, myotube 
morphology was normal (Fig. 4, C and D), and spontane- 
ous contraction of myotubes was sometimes observed, as 
with untreated C2 myotubes, indicating that the health of 
the cells was not significantly compromised. Consistent 
with this, the inhibitors did not affect AChR number, as 
assayed by binding of ~25I ot-bungarotoxin. Surface levels 
of receptor were equivalent for the carrier control (84_+ 4 
cpm/Izg protein [mean _ SEM]) and for the herbimycin- 
(83 -+ 9) and staurosporine-treated cultures (86 - 7). Fur- 
thermore, treated myotubes were able to recover when the 
inhibitors were removed and to subsequently cluster ecep- 
tors in response to agrin (data not shown). Finally, some of 
the other inhibitors that were tested did affect myotube 
morphology, but did not block receptor clustering. 
In double-labeling experiments, we also examined the 
effect of each inhibitor n the distribution of rapsyn, a cy- 
toplasmic peripheral membrane protein that is precisely 
codistributed with the AChR in clusters. In all of our ex- 
periments, clusters of the AChR were always accompa- 
nied by rapsyn and vice versa. Thus, the inhibitors acted to 
prevent or disperse the clustering of both proteins in con- 
cert (data not shown). 
Finally, we tested the effect of herbimycin and stauro- 
sporine treatment on preformed clusters. Surprisingly, we 
found that receptor clusters that had been induced by 1-2-d 
agrin treatment were completely dispersed after 6-8-h 
treatment with herbimycin and staurosporine at concen- 
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Figure 3. (A) Muscle agrin does not induce 13-subunit phosphory- 
lation. Phosphotyrosine immunoblot of AChR from C2 myotube 
cultures treated with muscle agrin (C-Ag0,0). Muscle agrin, even 
at a concentration f 10 nM, did not induce B-subunit phosphory- 
lation. (B) Neural agrin fails to induce 13-subunit phosphorylation 
in $26 myotubes. Phosphotyrosine immunoblot of AChR from 
$26 myotubes treated with neural agrin (C-Ag4.s). Neural agrin 
did not increase 13 phosphorylation when added at concentrations 
that do not induce receptor clustering (e.g., up to 100 nM). 
trations of over 1 ~M and 10 nM, respectively (Fig. 7). 
These results suggest hat tyrosine phosphorylation is re- 
quired not only for the formation but also for the stability 
and maintenance of agrin-induced AChR clusters. 
Discussion 
We have investigated the agrin signaling pathway in mam- 
malian muscle and find that it involves tyrosine phosphor- 
ylation of the AChR itself. Neural agrin induces a rapid 
but transient yrosine phosphorylation of the AChR 
subunit. Interestingly, [~-subunit phosphorylation begins 
over 2 h before the first discernible receptor clusters form 
and peaks 4-6 h before the peak in AChR cluster number. 
In fact, the level of tyrosine phosphorylation is in marked 
decline at precisely the time that cluster number is increas- 
ing towards its peak. Tyrosine phosphorylation of the [3 
subunit herefore appears to be lost upon receptor aggre- 
gation. The transient nature of the phosphorylation pro- 
vides an explanation as to why previous tudies in rat and 
mouse have not observed tyrosine phosphorylation in as- 
sociation with developing receptor clusters, nor tyrosine 
phosphorylation of the AChR until 1-2 wk postnatally 
(Qu et al., 1990; Campanelli et al., 1993). 
Studies in chick muscle have also shown that purified 
agrin, of unknown isoform, induces a rapid tyrosine phos- 
phorylation of the AChR i3 subunit (Wallace et al., 1991). 
The phosphorylation is not lost with receptor aggregation, 
however, and in contrast to mouse muscle, the developing 
clusters tain with antiphosphotyrosine antibodies. A fur- 
ther difference is that in chick muscle, innervation and 
agrin also induce tyrosine phosphorylation f the 8 subunit 
(Qu and Huganir, 1994). Despite careful examination, we 
did not detect ~-subunit tyrosine phosphorylation i  C2 
mouse myotubes. Our results therefore xtend on the find- 
ings made in chick and suggest hat the agrin-induced 
phosphorylation of the 13 subunit is an early, precursor 
step to aggregation, rather than being involved in the 
maintenance ofclusters. 
Several observations point to agrin-induced 13-subunit 
phosphorylation being a critical element in the clustering 
pathway. First, we observe a precise correlation between 
the extent of 13-subunit phosphorylation a d the level of 
receptor clustering seen over a wide range of concentra- 
tions of neural agrin. Second, muscle agrin, which is 10,000- 
fold less active in inducing receptor clustering than neural 
agrin, did not induce 13-subunit phosphorylation. Third, 
neural agrin did not induce 15-subunit phosphorylation in 
two proteoglycan mutants that have a significantly re- 
duced clustering response to agrin. Under several different 
experimental conditions, therefore, the extent of [3-subunit 
tyrosine phosphorylation is correlated with the presence 
or absence of receptor clustering. 
Finally, and most importantly, agrin-induced [5-subunit 
phosphorylation is completely blocked by the inhibitors, 
herbimycin and staurosporine. As these tyrosine kinase in- 
hibitors also block receptor clustering, phosphorylation f 
the AChR may thus be a required step for aggregation. 
Both herbimycin and staurosporine blocked r ceptor clus- 
tering in a dose-dependent manner, and several controls 
and observations confirm that the block by the inhibitors 
was not a nonspecific or toxic effect. Treatment with the 
inhibitors did not adversely affect myotube morphology, 
contractile activity, or levels of surface AChR. Moreover, 
after removal of inhibitor, the myotubes were able to re- 
cover and form agrin-induced AChR clusters. Our results 
thus strengthen the finding in chick muscle that both 
AChR clustering and [5-subunit tyrosine phosphorylation 
are blocked by staurosporine (Wallace, 1994). 
A direct est of the role of [5-subunit tyrosine phospt Jr- 
ylation in clustering has been made using a nonmu~cl ~.c~ll 
system. When rapsyn is coexpressed with the ACh2 in 
nonmuscle cells, it induces the formation of small receptor 
aggregates (Froehner et al., 1990; Phillips et al., 1991). Mu- 
tation of the relevant yrosine in the [3-subunit intracellu- 
lar loop (Wagner et al., 1991; Huganir and Miles, 1989) did 
not prevent this aggregation (Yu and Hall, 1994). The rap- 
syn-induced clustering in nonmuscle cells, however, may 
not accurately reflect he regulated clustering that occurs 
in myotubes. First, tyrosine kinase inhibitors fail to block 
the AChR/rapsyn aggregation i  COS cells (Taylor, R., 
and Z. Hall, unpublished observations). Second, in nonin- 
nervated muscle cells rapsyn and the AChR do not nor- 
mally form a significant number of spontaneous receptor 
clusters, but are diffusely distributed at the cell surface. 
Thus, experiments in muscle cells will be required to de- 
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Figure 4. Inhibition of agrin-induced AChR clustering by herbimycin and staurosporine. C2 myotubes either were untreated (A), or 
were treated with agrin in the presence of a carrier control (B), 1 t~M herbimycin (C), or 10 nM staurosporine (D). Cultures were 
stained with rhodamine-conjugated e~-bungarotoxin to assay receptor clustering. Herbimycin and staurosporine both completely inhib- 
ited agrin-induced AChR clustering. Bar, 10 Ixm. 
termine if 13-subunit phosphorylation is required for agrin- 
induced clustering of the AChR. 
The agrin-induced tyrosine phosphorylation of the 13 
subunit and the effect of the inhibitors suggests that the 
agrin signaling pathway in mammalian muscle involves ac- 
tivation of tyrosine kinases. Potentially, the pathway could 
require a receptor tyrosine kinase activated by agrin bind- 
ing, a cytoplasmic tyrosine kinase associated with a nonki- 
nase receptor, or a kinase involved in a downstream sig- 
naling event. As the known specificities of the two effective 
Figure 5. Dose dependence of inhibition of 
clustering by herbimycin and staurosporine. 
The number of AChR clusters per field was 
determined for myotube cultures treated with 
agrin alone or with agrin in the presence of a 
range of concentrations of herbimycin and 
staurosporine. Agrin alone induced a 10-fold 
increase in the number of receptor clusters. 
The increase in clustering was inhibited by 
both herbimycin and staurosporine in a dose- 
dependent manner. 
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Figure 6. Agrin-induced 13-subunit phosphorylation is blocked by 
herbimycin and staurosporine. Phosphotyrosine immunoblot of 
AChR from myotube cultures treated with a carrier control, 
agrin alone (100 pM), or agrin in the presence of 1 ~M herbimy- 
cin or 10 nM staurosporine. The agrin-induced increase in 13 
phosphorylation is blocked by both inhibitors, under the same 
conditions in which they block agrin-induced AChR clustering. 
inhibitors differ, the identity of the critical kinase(s) is un- 
clear. Herbimycin is reported to be a relatively specific in- 
hibitor of protein tyrosine kinases, especially of the src 
family. Staurosporine is less specific, however, and is 
known to inhibit not only some receptor tyrosine kinases, 
but also protein kinase C and cyclic nucleotide-dependent 
kinases. Another possibility is that the two inhibitors may 
not act on the same kinase, but may affect distinct kinases 
at different points in the signaling pathway. 
Agrin signaling may well involve tyrosine phosphoryla- 
tion of proteins in addition to the AChR. Consistent with 
this possibility, the maintenance of receptor clusters was 
found to be dependent on tyrosine phosphorylation, even 
though [3-subunit phosphorylation is lost by that time and 
is unlikely to be involved. The ability of herbimycin and 
staurosporine both to block cluster formation and to dis- 
perse clusters suggests that the same tyrosine kinase may 
be involved in each case. One possibility is that an inhibi- 
tor-sensitive kinase phosphorylates the [3 subunit and is re- 
cruited to clusters along with the AChR, where it may 
then act on other proteins. A number of proteins that are 
concentrated at the neuromuscular junction contain ty- 
rosine phosphorylation consensus sites, or have been 
shown to be tyrosine phosphorylated in Torpedo electric 
organ. These include integral membrane proteins ([3-dys- 
troglycan [Ibraghimov-Beskrovnaya et l., 1992]), mem- 
brane-associated proteins (rapsyn and the 58-kD protein 
[Froehner, 1991; Adams et al., 1993]), and cytoskeletal e e- 
Figure 7. Dispersal of preformed AChR clusters by herbimycin 
and staurosporine. Myotube cultures that had been previously 
treated with agrin to induce AChR clusters were treated with a 
carrier control (A), 2 ~M herbimycin (B), or 20 nM staurosporine 
(C). Preformed dusters were dispersed by both inhibitors after 6--8 h. 
Bar, 10 ~m. 
ments (the 87-kD protein and paxillin [Wagner et al., 1993; 
Gumbiner, 1993]). Agrin-induced phosphorylation f such 
proteins may also be required for cluster formation or 
maintenance. 
Given the complexity of the postsynaptic structure, it 
seems likely that the agrin signaling pathway governing its 
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assembly will be complex and will involve regulatory steps 
in addition to tyrosine phosphorylation. This is supported 
by the fact that clustering can be blocked not only by ty- 
rosine kinase inhibitors, but also by phorbol esters, which 
activate protein kinase C (Wallace et al., 1991), and by 
orthovanadate, a phosphatase inhibitor. Orthovanadate is 
interesting in that it increases the level of 13-subunit phos- 
phorylation, yet blocks agrin-induced clustering in both 
chick (Wallace, 1995) and mouse myotubes (Ferns and 
Hall, 1992) (data not shown). Thus, 13-subunit yrosine 
phosphorylation is not sufficient, in itself, to produce clus- 
tering of receptor. Clearly a coordinated interplay of ty- 
rosine kinase and phosphatase activity is required for ag- 
gregation. 
Overall, our findings provide strong correlative evi- 
dence linking 13-subunit phosphorylation and receptor 
clustering. Our findings suggest the following general 
model for agrin-induced receptor clustering. In uninner- 
vated muscle, the AChR is diffusely distributed and is not 
tyrosine phosphorylated. Upon innervation, neural agrin 
binds its receptor, inducing the activation of tyrosine ki- 
nases that phosphorylate the AChR and possibly other 
proteins. Tyrosine phosphorylation then regulates the as- 
sociation of the AChR with proteins that link it to the cy- 
toskeleton and result in its recruitment into clusters. These 
proteins may include the utrophin-associated complex. Af- 
ter aggregation, tyrosine phosphorylation of the AChR is 
lost in mammalian muscle, but the tyrosine phosphoryla- 
tion of other proteins required for the further develop- 
ment and maintenance of clusters is maintained. An im- 
portant future area of interest will be to define the protein 
interactions of the AChR that are regulated by tyrosine 
phosphorylation. 
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